Engaging patients to improve cancer genome sequencing
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center
['FUNDING_OTHER'] · OHIO STATE UNIVERSITY · NIH-10925225
This study is all about improving cancer treatment by involving patients in gathering and understanding genetic information, especially for rare and tough-to-treat cancers, so that everyone can help find better ways to fight the disease together.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OHIO STATE UNIVERSITY (nih funded) |
| Locations | 1 site (Columbus, UNITED STATES) |
| Trial ID | NIH-10925225 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing cancer treatment by engaging patients in the collection and analysis of genomic data. It aims to identify genetic differences between cancerous and normal cells, particularly in rare and aggressive cancers. The project will establish a Participant Engagement Community to ensure diverse participation and promote equitable outreach. By coordinating efforts and sharing best practices, the research seeks to fill gaps in genomic data that can lead to better treatment options.
Who could benefit from this research
Good fit: Ideal candidates include individuals diagnosed with rare or aggressive cancers, particularly those from underrepresented minority groups.
Not a fit: Patients with common cancers that are well-studied may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for various types of cancer.
How similar studies have performed: Previous research in cancer genomics has shown significant advancements, indicating that this approach has the potential for success.
Where this research is happening
Columbus, UNITED STATES
- OHIO STATE UNIVERSITY — Columbus, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BRIDGES, JOHN F. — OHIO STATE UNIVERSITY
- Study coordinator: BRIDGES, JOHN F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Advanced Cancer, Cancer Biology, Cancer Treatment, Cancers